Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomas Deierborg

Showing results (81-90 of 94) with videos related to

Pageof 10
Sort By:
Parkinson'S Disease|June 8, 2026
Early Amyloid Formation and Neuroinflammatory Response in a Bigenic Mouse Model Expressing Human α-Synuclein and AβRadhika Thakore, Markus Aldén, Nadja Gustavsson, et al.
Experimental Neurology|June 13, 2017
Fumarate decreases edema volume and improves functional outcome after experimental strokeBettina Hjelm Clausen, Louise Lundberg, Minna Yli-Karjanmaa, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 29, 2023
Galectin-3 is upregulated in frontotemporal dementia patients with subtype specificitySergi Borrego-Écija, Agnès Pérez-Millan, Anna Antonell, et al.
Journal of Neuroinflammation|December 16, 2014
Systemically administered anti-TNF therapy ameliorates functional outcomes after focal cerebral ischemiaBettina Hjelm Clausen, Matilda Degn, Nellie Anne Martin, et al.
Plos One|May 1, 2023
A comparison of machine learning approaches for the quantification of microglial cells in the brain of mice, rats and non-human primatesDanish M Anwer, Francesco Gubinelli, Yunus A Kurt, et al.
Scientific Reports|July 8, 2016
Conditional ablation of myeloid TNF increases lesion volume after experimental stroke in mice, possibly via altered ERK1/2 signalingBettina Hjelm Clausen, Matilda Degn, Mithula Sivasaravanaparan, et al.
Neurobiology of Disease|October 9, 2007
Increased metabolism in the R6/2 mouse model of Huntington's diseaseJorien M M van der Burg, Karl Bacos, Nigel I Wood, et al.
Acta Neuropathologica|July 27, 2022
Galectin-3 is elevated in CSF and is associated with Aβ deposits and tau aggregates in brain tissue in Alzheimer's diseaseAntonio Boza-Serrano, Agathe Vrillon, Karolina Minta, et al.
Cell Reports|March 11, 2015
Microglia-Secreted Galectin-3 Acts as a Toll-like Receptor 4 Ligand and Contributes to Microglial ActivationMiguel Angel Burguillos, Martina Svensson, Tim Schulte, et al.
Scientific Reports|January 28, 2017
Galectin-3 released in response to traumatic brain injury acts as an alarmin orchestrating brain immune response and promoting neurodegenerationPing Kei Yip, Alejandro Carrillo-Jimenez, Paul King, et al.
Pageof 10

Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
Parkinson'S Disease|June 8, 2026
Early Amyloid Formation and Neuroinflammatory Response in a Bigenic Mouse Model Expressing Human α-Synuclein and AβRadhika Thakore, Markus Aldén, Nadja Gustavsson, et al.
Experimental Neurology|June 13, 2017
Fumarate decreases edema volume and improves functional outcome after experimental strokeBettina Hjelm Clausen, Louise Lundberg, Minna Yli-Karjanmaa, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 29, 2023
Galectin-3 is upregulated in frontotemporal dementia patients with subtype specificitySergi Borrego-Écija, Agnès Pérez-Millan, Anna Antonell, et al.
Journal of Neuroinflammation|December 16, 2014
Systemically administered anti-TNF therapy ameliorates functional outcomes after focal cerebral ischemiaBettina Hjelm Clausen, Matilda Degn, Nellie Anne Martin, et al.
Plos One|May 1, 2023
A comparison of machine learning approaches for the quantification of microglial cells in the brain of mice, rats and non-human primatesDanish M Anwer, Francesco Gubinelli, Yunus A Kurt, et al.
Scientific Reports|July 8, 2016
Conditional ablation of myeloid TNF increases lesion volume after experimental stroke in mice, possibly via altered ERK1/2 signalingBettina Hjelm Clausen, Matilda Degn, Mithula Sivasaravanaparan, et al.
Neurobiology of Disease|October 9, 2007
Increased metabolism in the R6/2 mouse model of Huntington's diseaseJorien M M van der Burg, Karl Bacos, Nigel I Wood, et al.
Acta Neuropathologica|July 27, 2022
Galectin-3 is elevated in CSF and is associated with Aβ deposits and tau aggregates in brain tissue in Alzheimer's diseaseAntonio Boza-Serrano, Agathe Vrillon, Karolina Minta, et al.
Cell Reports|March 11, 2015
Microglia-Secreted Galectin-3 Acts as a Toll-like Receptor 4 Ligand and Contributes to Microglial ActivationMiguel Angel Burguillos, Martina Svensson, Tim Schulte, et al.
Scientific Reports|January 28, 2017
Galectin-3 released in response to traumatic brain injury acts as an alarmin orchestrating brain immune response and promoting neurodegenerationPing Kei Yip, Alejandro Carrillo-Jimenez, Paul King, et al.
Pageof 10